A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma
一项II期研究，评估硼替佐米联合利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松治疗既往未接受治疗的惰性非霍奇金淋巴瘤患者的疗效。
期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.13637
Cohen, Jonathon B; Switchenko, Jeffrey M; Koff, Jean L; Sinha, Rajni; Kaufman, Jonathan L; Khoury, H Jean; Bumpers, Nassoma; Colbert, Amanda; Hutchison-Rzepka, Amanda; Nastoupil, Loretta J; Heffner, Leonard T; Langston, Amelia A; Lechowicz, Mary Jo; Lonial, Sagar; Flowers, Christopher R
